Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4523344 Target Snapshot

Methylcytosine dioxygenase TET2 · SINGLE PROTEIN · Homo sapiens

95Compounds
23Assays
3Approved Drugs
130.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q6N021. Use UniProt Q6N021 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q6N021 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Methylcytosine dioxygenase TET2 as ChEMBL target CHEMBL4523344, mapped to UniProt Q6N021. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Methylcytosine dioxygenase TET2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4523344
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q6N021
Methylcytosine dioxygenase TET2
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Methylcytosine dioxygenase TET2 is the right protein anchor across sources, using UniProt Q6N021 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMethylcytosine dioxygenase TET2
UniProt AccessionQ6N021
Component TypeProtein
Sequence Length2002 aa

Methylcytosine dioxygenase TET2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Methylcytosine dioxygenase TET2, mapped to UniProt Q6N021. Sequence length is 2002 aa.

Mapped IDQ6N021
Review nameMethylcytosine dioxygenase TET2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

3
Approved
Assay Mix

Activity Type Distribution

IC50117.0
KI2.0
EC507.0
KD4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5527999 6.91 IC50 123.03 Preclinical
CHEMBL5565375 6.6 IC50 250.0 Preclinical
CHEMBL4851104 6.52 Kd 300.0 Preclinical
CHEMBL3785455 6.45 IC50 354.81 Preclinical
CHEMBL1230640 6.26 IC50 549.54 Preclinical
CHEMBL4855677 6.21 Kd 610.0 Preclinical
CHEMBL5561497 6.08 IC50 831.76 Preclinical
CHEMBL5562105 6.03 IC50 933.25 Preclinical
CHEMBL5532540 5.95 IC50 1122.02 Preclinical
CHEMBL4872206 5.92 IC50 1200.0 Preclinical
Distribution

pChEMBL Value Distribution

21
5.0
21
5.5
6
6.0
4
6.5
0
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

23
Total Assays
67
Tested Compounds
1
Assay Types
Binding — 23 assays, 67 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 9 45 5.2
cell-based format 8 16 5.0
single protein format 6 6 5.7

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine